COVID-19. Kedrion partners with Columbia University Irving MC
Kedrion and Columbia University release video statements
Kedrion-Kamada collaboration for Anti Covid-19 IgG
The companies announced cooperation for developing Anti Covid-19 therapy
Coronavirus – from plasma an anti Covid-19 treatment
Kedrion’s commitment to find a treatment from convalescent patient plasma
Letter to patient associations and scientific organizations
Communication from Paolo Marcucci, Chairman & CEO of Kedrion
Kedrion Statement on the novel Coronavirus
In accordance with international, national and local authority guidelines, Kedrion has acted immediately in dealing with the epidemiological emergency linked to the spread of the new Coronavirus (SARS-CoV-2), and has taken all necessary measures to safeguard the health and safety of its employees and guarantee continuation of business activities. Paolo Marcucci, Chairman & CEO has
Kedrion-supported scientific symposium at the MANIT Conference in Hungary
The company reaffirms its commitment to Hungarian clinicians working in the field of dysimmune neurological diseases
As per tradition, Kedrion at the Italian embassy event
The company participated in the reception for the Italian Republic Day in Budapest
EIGHT, the international conference on Hemophilia A
Experts from all over the world at EIGHT 2018 in Budapest
Kedrion attends Italian embassy event in Budapest
The company strenghten the good relationship with local communities
Kedrion Biopharma joins IPOPI in supporting patients with APP PID Genius
This new APP, presented at the IPIC Congress in Dubai, will be the personal assistant to people living with PIDs